SGLT2i improves outcomes in HFpEF and HFmrEF
This video was recorded during the ESC Congress 2022 in Barcelona, Spain.
Scott D. Solomon, MD is the Edward D. Frohlich Distinguished Chair, Professor of Medicine at Harvard Medical School and directs the Clinical Trials Outcomes Center at Brigham and Women’s Hospital.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: